FOR IMMEDIATE RELEASE
Contact: Murray Penner
July 29, 2013, Washington, DC – As part of ongoing efforts by the ADAP Crisis Task Force (Task Force) and the pharmaceutical industry to address the continued need for access to HIV antiretroviral medicines through AIDS Drug Assistance Programs (ADAPs), the Task Force announced today that it has reached agreement with AbbVie, Gilead Sciences, Merck, and ViiV Healthcare to extend the voluntary discounts/rebates and price freezes available to all state ADAPs through December 31, 2014.
By Emily McCloskey, Manager, Policy and Legislative Affairs, NASTAD
Action: Contact your Senators to ask them to fully fund domestic HIV/AIDS and viral hepatitis programs
The Senate Appropriations Committee is expected to vote on the bill that funds domestic HIV/AIDS and viral hepatitis programs the week of July 7. The National Alliance of State and Territorial AIDS Directors (NASTAD) and the larger HIV community are leading a call in day on June 27 to ask the Senate to help prevent further cuts and to fully fund domestic HIV/AIDS and viral hepatitis prevention, care, treatment, and research programs. Calls on this issue to individual offices can make a difference. Please send the action alert to your networks and communities. If possible, NASTAD also asks you to reach out to your Senators on June 27, National HIV Testing Day (NTHD), and let them know the importance of HIV and viral hepatitis programs. Continue reading
By Chis Hanson, AIDS Drug Assistance Program (ADAP) Coordinator, Michigan Department of Community Health
Chris Hanson, ADAP Coordinator, Michigan Department of Community Health
In collaboration with the Health Resources and Services Administration (HRSA) and as a component of our HRSA Cooperative Agreement, NASTAD is releasing a set of videos related to AIDS Drug Assistance Program (ADAP) efficiency and program management. These videos are a companion to the ADAP Technical Assistance (TA) brief series released in winter 2012. Throughout the course of the past year, NASTAD compiled lessons learned from ADAP coordinators on a variety of topics including the use of data, implementation of cost-containment measures, challenges and successes in managing an ADAP, and advice for working within the program. The videos being released today address challenges and successes in management and ADAP and include advice from seasoned ADAP coordinators for working within the program. Continue reading
By Oscar Mairena and Emily McCloskey, Managers of Policy & Legislative Affairs
As we begin to see the effects of the sequester on public health programs nationwide, it becomes increasingly clear that we must increase funding for HIV and viral hepatitis programs in FY2014 and onward in order to truly end these epidemics and improve the nation’s health. In light of this need, NASTAD has released fact sheets with recommendations for FY2014 health department HIV/AIDS and viral hepatitis program funding at the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA). Continue reading
FOR IMMEDIATE RELEASE: April 2, 2013
Contact: Meico Whitlock, 202-434-8094, www.NASTAD.org
ADAP Enrolling and Serving More Clients than Ever Before; Future Funding Uncertain
Washington, DC – Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released the second and final module of its 2013 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 18 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.